Lonza announces new spray-drying plant in Bend, Oregon as Samsung Bio secures $262 million contract
Lonza announced plans to construct a new commercial spray-drying facility in Bend, Oregon, expanding its manufacturing footprint in the United States.
The plant will increase Lonza’s capacity to produce sterile drug products and is part of a broader effort to meet growing demand for contract manufacturing services.
In related news, Samsung Bio reported signing a $262 million contract, underscoring continued investment in biopharmaceutical manufacturing capabilities.
The announcements come as the industry seeks to bolster supply chain resilience and meet rising demand for advanced therapies.
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Lonza to build new US factory; Samsung Bio signs $262M contract”
read at Endpoints ↗
comments(0)
5-min edit window · permanent after that